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Abstract.  Various factors are known to regulate cell 
growth and differentiation in epithelial-mesenchymal 
interactions. Keratinocyte growth factor (KGF), an 
epithelial-specific cytokine produced by dermal fibro- 
blasts and other mesenchymal cells, appears to affect 
growth, migration, and differentiation in epithelial- 
mesenchymal interactions. We have previously shown 
that human embryonic skin fibroblasts induce anchor- 
age-independent growth of HPV16  DNA-immortalized 
human uterine exocervical epithelial cells (HCE16/3 
cell line) in cocultures of HCE16/3 cells and fibro- 
blasts.  Here we report that KGF may be a major 
factor influencing growth and behavior of HCE16/3 
cells in the coculture system. KGF stimulated both 
DNA synthesis and proliferation of normal human 
cervical epithelial (HCE) cells and HCE16/3 cells 
and the increase was stronger in HCE16/3  ceils 
than in HCE cells. SiHa cells, a cervical carcinoma 
cell line with integrated HPV16  DNA, did not respond 
to the KGF mitogen signal. KGF receptor (KGFR) 
studies suggested that the different responses to the 
KGF mitogen signal may be correlated with KGFR. In 
addition, KGF alone was able to induce anchorage- 
independent growth of HCE16/3  ceils, suggesting a 
potential role for KGF in the transformation process of 
epithelial cells. However, the transcription of HPV16 
early genes was suppressed by KGF in the immortal- 
ized HCE16/3 cells, and this appeared to be due to 
transcriptional repression rather than a posttranscrip- 
tional process according to nuclear run-on analysis. In 
contrast, viral gene expression was not affected by 
KGF in SiHa cells. Our results suggest that KGF is a 
bifunctional growth factor in the HPV-immortalized 
cells, a positive regulator of cell growth and negative 
regulator of HPV16  early gene expression. 
T 
HE epitheliall-mesenchymal interaction  is a complex 
process.  Stromal  fibroblasts  synthesize  and  release 
keratinocyte growth factor (KGF) t and scatter fac- 
tor/hepatocyte growth factor (SF/HGF)  that influence epi- 
thelial cell growth and migration (Panos et al., 1993; Son- 
nenberg et al., 1993). On the other hand, epithelial cells also 
produce and secrete interleukin-1 affecting the metabolic ac- 
tivity of fibroblasts (Goldyne et al.,  1991). 
KGF is made by stromal  fibroblasts and belongs to the 
nine-member FGF family (Finch et al.,  1989; Aaronson et 
al.,  1991). In contrast to the other known members of the 
FGF family, KGF has a unique target cell specificity re- 
stricted to the epithelial cell type (Finch et al., 1989; Rubin 
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et al.,  1989), whereas acidic and basic FGF exert potent 
effects also on fibroblasts, endothelial cells, melanocytes  and 
neurons (Basilico and Moscatelli,  1992). KGF is synthesized 
as a single polypeptide precursor that is cleaved upon secre- 
tion to liberate mature KGF (Finch et al.,  1989). In vitro 
studies have shown that the stimulating effects of KGF on 
DNA synthesis in keratinocytes is 2- to 10-fold stronger than 
that of autocrine keratinocyte growth factors such as trans- 
forming growth factor alpha (TGF-a) and EGF (Rubin et al., 
1989). Molecular cloning of the KGF receptor established 
that it is a membrane-spanning tyrosine kinase derived from 
an alternatively spliced form of the bek (FGFR-2) gene. This 
alternatively spliced transcript has been detected only in epi- 
thelial cells and the potent mitogenic activity on epithelial 
cells  suggest that KGF  is  important in the physiological 
renewal of the epidermis. Guo et al. (1993) have shown that 
KGF has significant influence on the morphogenesis and or- 
ganogenesis during development.  Furthermore, Werner et 
al. (1992) recently reported strong induction of KGF expres- 
sion in the dermis during wound healing,  implicating that 
KGF-mediated effects may be important for the migration 
and proliferation  of epidermal keratinocytes  seen during 
wound healing. 
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lial carcinogenesis. Recent studies have shown that in the 
malignant progression, prostate epithelial cells cease to be 
responsive to KGF which can both support the growth of  epi- 
thelial cells and induce them to a differentiated state (Mar- 
chese et al., 1990; Yan et al., 1993). The HCE16/3 calls that 
were used in the present study,  are HPV16  DNA-immor- 
talized human cervical  epithelial  cells,  growing continu- 
ously and expressing early genes of HPV16  DNA, but fail 
to grow in soft agarose or in nude mice (Zheng et al., 1994). 
Their phenotype thus represents an early stage of  human epi- 
thelial carcinogenesis in the multistep model of tumor devel- 
opment in vitro. We have now investigated the effect of KGF 
(a) on DNA synthesis and cell proliferation of different cer- 
vical cell lines; (b) on anchorage-independent growth of nor- 
mal epithelial cells and immortalized epithelial cells; and (c) 
on HPV16 gene expression of  HCE16/3 cells and the HPV16- 
positive SiHa cervical carcinoma cell line. We also studied 
specific  binding of J25I-KGF to its receptor in the different 
cervical ceils. Our studies demonstrate that KGF strongly 
stimulates the growth of HCE16/3 ceils and induces their 
anchorage-independent growth, but perhaps a more interest- 
ing and unexpected result is that KGF markedly inhibited the 
expression of HPV16 early genes in HCE16/3  cells. 
Materials and Methods 
Cell Cultures 
The  HCE16/3  cell line (Zheng et al.,  1994)  consists of HPV16  DNA- 
immortalized human uterine ¢xocervical epithelial cells, which were cup 
tured in a 1:1 (vol/vol) mixture of Dulbecco's modified Eagle's medium and 
Ham's Nutrient  Mixture F12  (DME/F-12)  supplemented with 2%  heat- 
inactivated FCS, 2 mM L-glutamine, 100 IU/mi penicillin, 100/zg/ml strep- 
tomycin, 5/~g/ml insulin, 5/~g/ml transfcrrin, 400 ng/mi hydrocortisone, 
10  -1° M cholera toxin, and 5 ng/ml E(3F in a 5% CO2 incubator at 37°C. 
Characterization of HCEI6/3 cells has been described in detail previously 
(Zheng et ai., 1994).  The cells were shown to be free of mycoplasm as de- 
termined by a hybridization test (Mycoplasm TC; (3en-Probe, San Diego, 
CA) and were used between passages 40 and 51 in the present experiments. 
Normal human cervical epithelial (HCE) cells were prepared in this labora- 
tory as previously described (Zheng et al.,  1994) and were maintained in 
the same medium as HCEI6/3 cells. The culture medium was replaced three 
times per week. SiHa cells (HTB 35; obtained from American Type Culture 
Collection, Rockville, MD) derived from HPV16 DNA-positive cervical 
squamous carcinoma, were cultured in MEM supplemented with 10% FCS, 
2  mM  L-glutamine,  100  IU/ml penicillin, and  100  #g/ml  streptomycin 
(t0%-MEM). BALB/MK-2 cells (Weissman and Aaronson, 1983; a mouse 
epidermal  keratinocyte line)  were obtained  from  Dr.  Jorma  Keski-Oja 
(Department of Virology,  University of Helsinki) and  were cultured  in 
medium with the following composition: 482 mi of Ca2+-free  10%-MEM 
and 18 ml 10%-MEM). The medium was changed twice a week. 
Keratinocyte Growth Factor 
KGF was from Pepro Tech EC Ltd. (London, UK) and was reconstituted 
according to the manufacturer's recommendations. 
DNA Synthesis Assay 
BALB/MK-2, HCE (passage 2-3), HCEI6/3 and SiHa cells were grown in 
24-well  2-cm  2 plates ((3reiner,  Frickenhausan, Germany) for 3-4 d until 
the cultures were confluent. Cultures were serum-starved for 24 h (for HCE 
and HCE16/3 cells, the culture medium was used without the supplements). 
Then,  K(3F  (0,  3,  10,  30,  or  100  ng/ml) was added without change of 
medium; control cultures received the same volume of medium. 24 h later, 
the cells were labeled with 0.5  mCi/ml of [3H]thymidine (26  Ci/mmol; 
Amersham, Aylesbury,  UK) for 4 h. The labeling was terminated by wash- 
ing the cells three times with cold PBS and fixing them with 95% methanol 
for 90 rain at 4°C. The ceils were then washed with cold PBS and extracted 
with 0.2 M NaOH for 30 rain at 4°C. Liquid scintillation cocktail (Opti- 
Floor*; Packard Instrument Company, Meriden, CT) was added to aliquots 
of the cell extract and the incorporated radioactivity was determined in a 
liquid scintillation counter. Each assay was carded out in triplicate. 
Cell Proliferation  Assay 
BALB/MK-2, HCE (passage 2), HCEI6/3 and SiHa cells were grown in 12- 
well cell culture plates in their respective media containing 2%  serum 
(BALB/MK-2, HCEI6/3, SiHa) or (HCE) 2% serum and insulin, transfer- 
rin, hydrocortisone, cholera toxin, and E(3F as described above.  After in- 
oculation of 100,000 cells (BALB/MK- 2, HCE, HCEI6/3) or 60000 cells 
(SiHa) per dish different concentrations of K(3F was added. Triplicate wells 
were counted after two and four (BALB/MK-2, HCE16/3,  SiHa) or three 
and seven (HCE) days of culture. Growth medium was changed every sec- 
ond day. 
Iodination of  KGF 
Iodogen tubes were prepared by placing 20/zl of choloroform containing 
10 mg/mi Iodogen (l,3,4,6-tetrachloro-3~6cx-diphenylglycouril; Sigma Im- 
munochemicais, St. Louis, MO) in the bottom of 3-ml glass tubes and then 
allowed to air-dry. Recombinant KGF was labeled by mixing 3/~g KGF/100 
/zl PBS and 50/zl 4 mM EDTA, pH 7.8, in the iodinating tube, adding 0.5 
mCi t2~I/5 ~I and incubating for 2-3 rain at room temperature. The iodi- 
nated protein was isolated on a  disposable column containing Sephadex 
(3-25  (PD-10;  Pharmacia, Uppsala, Sweden) pretreated with 50 ml Dul- 
becco's PBS containing 0.5% BSA and washed with 100 ml PBS before use. 
The specific activity of n25I-KGF was 22,000  cpm/ng protein.  I2SI-KGF 
was checked on 12%  SDS-PA(3E. 
KGF Receptor Studies 
The receptor binding assay was carried out as described by Boaaro et al. 
(1990),  with small modifications. Briefly, confluent HCE cells (passage 3), 
HCEI6/3 cells and SiHa cells were cultured in 24-well plates and serum- 
starved for 24 h (for HCE and HCEI6/3 cells, the culture medium was used 
without the supplements). The cells were incubated with Hepes binding 
buffer (100 mM Hepes, 150 mM NaCl, 5 mM KCI, 1.2 mM MgSO4,  8.8 
mM dextrose, and 0.1%  BSA, pH 7.4) containing 125I-KGF for 3 h with 
shaking at 4°C. The labeling was terminated by washing the cultures with 
cold PBS three times. The cells wm'e then lysed with 0.5% SDS and the 
radioactivity was measured by a gamma counter. Each assay was carried 
out in duplicate. 
Cross-linking of ~25I-KGF  to receptor assay was also based on the previ- 
ous procedure (Bottaro et aI., 1990) with minor modifications. In short, the 
confluent HCEI6/3 cells in 100-mm dishes were serum starved for 24 h and 
then 20 ng/rnl  125I-KGF was added in the presence or absence of 100-fold 
excess of unlabeled K(3F. After 3-h incubation at 4°C,  the plates were 
washed three times with cold PBS and disuccinimidyl suberate was added 
as described by Olwin and Hanschka (1986).  After washing twice with cold 
PBS, the cells were scraped into 1 ml antiprot¢inase buffer (Hepes binding 
buffer containing 100 U/ml aprotinin and 1 mM PMSF), followed by cen- 
trifugation at 13,000 rpm at 4°C for 5 rain. Membrane-associated proteins 
were extracted for 30 rain in 35/zl of antiproteinase buffer containing 1% 
Triton X-100 at 4°C. After centrifugation, 35/~l Laemmii reducing sample 
buffer containing 100 mM DTT was added to the supernatant and the sam- 
pies were boiled for 3 rain. The samples were analyzed by 7.5 % SDS-PAGE 
(Laemmli, 1970) and the dried gel was exposed to Kodak X-Omat film at 
-70°C with an intensifying screen. 
Soft Agarose Assay 
Cell culture 24-well plates were first coated with 0.5 ml of 0.64%  sterile 
agarose (SeaPlaque agarose; FMC BioProducts, Rockland, ME) in 1.67-fold 
DME basal medium supplemented with 20%  FCS. The agarose medium 
was solidified in a laminar hood. Next, 1.2-ml aliquots of 1.67-fold DME 
containing 16% FCS were prepared in 6-ml Falcon  ® tubes (2063; Becton 
Dickinson,  Lincoln  Park,  NJ)  and  either  104  BALB/MK-2,  HCE,  or 
HCE16/3 cells with KGF (0, 50, or 100 ng/ml) were added. SiHa cells were 
used as a positive control. Then 0.8 ml of 1.0% sterile agarose, premeltexi 
and cooled to 450C,  was added to the tubes, mixed gently, and this mixture 
was layered on the precoated wells. The plates were cultured in a 5 % CO2 
incubator at 37°C for 3 wk without further feeding. Colonies were scored 
after 14-18 d using an inverted microscope. 
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HCEI6/3 and SiHa ceils were plated in 100-mm-diam dishes. To avoid the 
possibility that down-regulation  of HPV gene expression by KGF might oc- 
cur secondarily due to cessation of cell proliferation, subconfluent prolifer- 
ating cultures  were used for the experiments.  The medium was replaced 
with fresh medium containing KGE Northern blotting was carried out as 
previously described (Zheng et al.,  1994). Briefly, total RNA was isolated 
by lysis of cells in guanidine thiocyanate and centrifugation through a CsC1 
cushion. 25/zg of RNA was fractionated  on a 1.2% agarose gel containing 
6.6%  formaldehyde  and  transferred to  membranes  (Hybond~'-C  extra; 
Amersham) and the hybridization was performed as previously  described. 
The HPV16  E7 probe was generated by polymerase chain reaction am- 
plification  of the E7 open reading  frame on the template of HPV16 DNA 
(Zheng et al., 1994). The HPV 16 E6 probe was excised by PstI and EcoRI 
digestion  from pEBF16/4  B  plasmid  (Fig.  1),  kindly provided by  Dr. 
Thomas Iftner (Institut ~r Klinische and Molekulare Virologic,  Erlangen, 
Germany). This plasmid contained a fragment of HPVI6 spanning nucleo- 
tides 7455-551 in the vector pGEM1 from Stratagena Inc. (La Jolla, CA). 
The plasmid was then transfected  into Escherichia coli JM 109, amplified 
and purified with conventional methodology. Glyceraidehyde phosphate de- 
hydrogenase probe was used to monitor the total RNA loading. Densitomet- 
ric analysis was performed using a Rapid Electrophoresis  Analyzer (Helena 
Laboratories, Beaumont, TX). 
Nuclear Run-on Analysis 
Subconfluent cells were grown in the presence or absence of 20 ng/ml of 
KGF for 24 h. After washing with cold PBS, cells were scraped and washed 
once with cold PBS. Isolation of nuclei from cells and nuclear run-on assay 
were performed basically using the method of Greenberg and Ziff (1984). 
Briefly, cells (2.5  ×  107) were suspended  in reticulocyte  standard buffer: 
10 mM Tris-HCl pH 7.4,  10 mM NaCI,  5 mM MgCI2, and 1 mM DTT, 
and lysed by addition of Nonidet P-40 to a final concentration of 0.2% 
(vol/vol). The nuclear pellet was obtained by centrifugation at 500 g for 5 
rain at +4°C and then washed once in reticulocyte  standard buffer. Nuclei 
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Figure  L  Molecular  structure  of  the  recombinant  plasmid 
pEBF16/4  B,  which  contains  a  fragment  of HPV16  spanning 
nucleotide 7455 (EcoRI) -551  (PvuID in the vector pGEM1 from 
Stratagene. Since the blunt end of PvulI is joined with the blunt end 
of Sinai, this fragment is not recognized by PvuII and SmaI any- 
more; thus the used HPV16 E6 probe is between EcoRI and PstI. 
The genomic organization of the HPVI6 DNA is shown on top of 
the figure (numbers indicate corresponding nucleotide sites). 
were stored in 100/~1 of 50 mM Tris-HCl, pH 8.3, 40% glycerol,  5 mM 
MgCI2, and 0.1  mM EDTA at  -70"C.  For nuclear ran-on assay, nuclei 
were thawed and mixed with 100/~1 reaction buffer (10 mM Tris-HCl, pH 
8.0, containing 5 mM MgCI2, 300 mM KCI, and 5 mM DTT, 0.5 mM each 
ATE CTP, GTP), and 100/~Ci [a-32P]UTP (800 Ci/mmol), and incubated 
at 30°C  for 30 min. The 32p-labeled RNA was isolated by isopropanol- 
ammonium acetate precipitation. The HPV16 and B-aetin cDNA inserts (1 
~g/dot) were denatured by incubation with 0.1 M NaOH for 30 rain at room 
temperature.  The DNA was immobilized  on nylon membranes (Pall Bio- 
Support Corp.; Glen Cove, NY) using a dot blot apparatus.  Subsequently, 
the filters were dried and baked at 80°C for 2 h and prehybridized  with the 
same solution as Northern blots. The filters were hybridized under the same 
conditions for 48 h in hybridization solution containing the elongated tran- 
scripts at 6.0  x  106 cpm/ml in each assay. After the hybridization,  the 
filters were washed with 1  × SSC and 0.1% SDS for 30 rain at room tempera- 
ture and 0.2x  SSC and 0.1% SDS  for 30 rain at 60°C and treated with 
RNase in 2 x  SSC. Finally, the filters were exposed to Kodak AR X-Omat 
films at 70"C with an intensifying  screen. The intensity of hybridization  was 
measured  by the scanning analyzer as Northern blots were. 
Results 
Stimulation of  liCE16~3 cell Proliferation by KGF 
The effect of KGF on cell growth was examined with a series 
of cell lines derived from human cervical epithelial cells. 
The  primary  objective  was  to  determine  whether  KGF 
affected DNA synthesis and cell proliferation in a different 
manner in different human cervical epithelial cells. Effect of 
recombinant human  KGF on  pH]thymidine incorporation 
in  HCE,  HCE16/3,  and  SiHa  cells,  is  shown  in  Fig.  2. 
BALB/MK-2 cell line was used as a control cell line known 
to respond to KGF (Rubin et al., 1989). HCE and HCE16/3 
cells  both  responded  to  KGF  stimulation.  In  HCE  cells 
[3H]thymidine incorporation  increased  1.6-fold  after addi- 
tion of 10 rig KGF/rnl and the uptake increased only slightly 
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Figure 2. Effect of KGF on DNA synthesis as determined by incor- 
poration of pH]thymidine in HCE16/13, HCE, SiHa, and BALB/ 
MK-2 cell  lines. Confluent cell cultures  were serum-starved  for 
24 h and then exposed to 0, 3, 10, 30, or 100 ng/ml of KGF without 
change of medium. 24 h later, the cells were labeled for 4 h with 
[3H]thymidine. The incorporated radioactivity was determined  in 
a liquid scintillation counter. These data are the results (+ SE) of 
a single experiment performed in triplicate.  The experiment was 
repeated twice with similar results. 
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incorporation of HCE16/3 cells was stimulated 3.6-fold by 10 
ng/ml KGF  and  it  also  increased  slightly  with  increasing 
KGF concentrations. The observed increase in DNA synthe- 
sis was maximal, *4.2-fold, at 30-100 ng/rnl of the growth 
factor. In contrast to HCE and HCEI6/3 cells, the [3H]thy-  o 
20 
midine incorporation of SiHa cells was not affected by KGE 
The effect of  KGF on cell proliferation correlated well with 
the above effects on thymidine incorporation (Fig.  3). 
Presence of  KGF Receptors on HPV16 DNA 
Immortalized Human Cervical Epithelial Cells  ,z  10 
To investigate whether the different effects of KGF on DNA 
synthesis of HCE, HCE16/3 and SiHa cells were a result of  ~, 
differences  in  KGF  receptors,  we  studied  the  binding  of 
¢q 
~2q-KGF  in  these  cell  lines.  Specific  binding  was  deter-  "~ 
mined by subtracting the activity found in samples incubated  0 
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Figure 3.  Effect  of KGF on proliferation  as determined by cell 
counting.  Sparse cultures  of SiHa,  HCE,  HCEI6/3, and BALB/ 
MK-2 cells were stimulated with increasing concentrations of KGF, 
and cells in triplicate  wells were counted as indicated.  The cervical 
carcinoma ceils (SiHa) did not respond to KGF, whereas both nor- 
mal and transformed  cervical epithelial  cells and mouse keratino- 
cytes showed a dose-dependent increase  in cell  number with in- 
creasing  concentrations of the  growth factor,  u,  0  ng/ml;  t3,  1 
ng/ml;  ,,, 3 ng/ml; zx, 10 ng/ml;  Q, 30 ng/ml. 
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Figure 4.  Binding  of t25I-KGF to KGF receptors in three human 
cervical cell lines. Confluent culture ceils were cultured  in 24-well 
2-cm  2 plates and serum-starved for 24 h. The cells were incubated 
with Hepes binding buffer containing t25I-KGF  for 3 h at 4°C. The 
labeling  was terminated  by washing  the cultures  with  cold PBS 
three times. The cells were then lysed with 0.5 % SDS and the radio- 
activity  was measured in a gamma counter.  Background binding 
(subtracted)  was determined in the presence of 100-fold excess of 
cold ligand and 3 #g/ml beparin.  The data plotted are the mean of 
duplicate  points. 
with  100-fold excess  of unlabeled  KGF  from the  activity 
bound to the cells in the absence of unlabeled KGE All the 
experiments  were  carried  out in  the  presence  of 3  #g/ml 
heparin.  HCE  cells  bound  less  KGF  than  HCE16/3  cells 
(Fig. 4). As expected SiHa cells exhibited no specific binding 
of 125I-KGF to its  receptor.  Covalent affinity cross-linking 
of t25I-KGF to its receptor on HCE16/3 cells was detected 
on  SDS-PAGE.  A  single  t2q-labeled  band  was  observed 
migrating  at  an  apparent  molecular mass of over 200  kD 
(Fig. 5). This complex, though somewhat larger than that de- 
scribed by others (Bottaro et al.,  1990; Miki et al.,  1992), 
Figure  5.  mI-KGF  cross- 
linking  to  KGF  receptor  in 
HCE16/3  cells.  Confluent 
HCEI6/3  cells  in  100-ram 
dishes were serum-starved for 
24 h. 20 ng/ml I25I-KGF  were 
added in the presence or ab- 
sence of 100-fold excess of  un- 
labeled KGE After a 3-h incu- 
bation at 4°C, the plates were 
washed  three  times  with cold 
PBS and disuccinimidyl sub- 
crate was added. The samples 
were analyzed by 7.5%  SDS- 
PAGE under  reduced  condi- 
tions and the dried gel was ex- 
posed for 3 d at  -70°C. The 
second lane (labeled  +) indi- 
cates  the  cross-linking  per- 
formed in the presence of 100-fold excess of unlabeled  KGE The 
migration of molecular size standards (kD)  is shown on the left. 
The Journal of Cell Biology, Volume 129, 1995  846 Figure 6. KGF-induced  anchor- 
age-independent  growth  of 
HCEI6/3  cells.  (a)  104 
BALB/MK-2  cells;  (b)  104 
BALB/MK-2 cells with 50 ng/ 
ml  of KGF;  (c)  104  normal 
HCE cells at passage 2;  (d) 
104  normal  HCE  cells  with 
50  ng/ml  of  KGF;  (e)  104 
HCEI6/3  cells  at  passage 
43;  (f)  104  HCEI6/3  cells 
with  50  ng/ml of KGF;  (g) 
104  HCEI6/3  cells  with  50 
ng/ml of KGF and addition of 
50 ng/ml of KGF every three 
days,  total  three  times;  (h) 
104 SiHa cells  without KGF 
as a positive control. 
was abolished in the presence of 100-fold excess:of  unlabeled 
KGF,  demonstrating  specific  binding  of  ~25I-KGF to  its 
receptor. 
KGF-induced Anchorage-independent Growth of 
HCE16/3 Cells 
Neither normal  cervical epithelial  cells  nor BALB/MK-2 
cells, which respond to KGF stimulation by increased DNA 
synthesis, were able to grow in soft agarose in the absence 
or presence of KGF  (50-100  ng/ml)  while KGF induced 
anchorage-independent growth of the immortalized HCE16/3 
cells at these concentrations (Fig.  6). Generally, HCE16/3 
cells began to form visible colonies after 7-10 d. However, 
these colonies usually did not become very large and con- 
sisted of only 3-10 cells in most experiments. When cocul- 
tured  with  fibroblasts,  HCE16/3  cells  formed larger  and 
more numerous colonies, nearly as effectively  as SiHa cells, 
as previously reported (J. Zheng and A. Vaheri, manuscript 
submitted  for  publication).  In  separate  experiments,  we 
tested the dose-dependent effect of KGF (0,  10, 25,  50, and 
100 ng/ml) on anchorage-independent growth of HCE16/3 
cells.  Although  the  maximal  cellular  response  to  KGF 
showed some variation from assay to assay, we found that 50 
ng/ml of KGF was required to obtain a clearly positive re- 
suit. The size and number of colonies induced by KGF was 
not significantly different between the concentrations 50 and 
100 ng/ml. Generally each well contained ~230-600 colo- 
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ever, feeding additional KGF during the culture period in- 
creased the colony size (consisting of 10-100 calls), but did 
not significantly influence the colony number (Fig. 6 g). In 
separate  experiments,  neither  bFGF  (50  ng/ml;  kindly 
provided by Dr. Andreas Sommer, Synergen, Inc., Boulder, 
CO) nor scatter factor (50-100 ng/ml; kindly provided by 
Drs.  Water  Birehmeier  and  Martin  Sachs,  MDC  Max- 
Delbruck-Centrum, Berlin,  Germany) alone could induce 
anchorage-independent growth of HCE16/3 cells or to have 
synergy with KGF in the induction of anchorage-indepen- 
dent growth of HCE16/3 cells (data not shown). 
Inhibition of HPV16 Gene Expression of  KGF 
HPV16  early gene expression is  thought to  be primarily 
responsible for the continuous growth of HPV-immortalized 
cells in culture. HCE16/3 cells express three different mRNA 
species (1.7, 2.4, and 3.7 kb) hybridizing with the HPVI6 E7 
probe, and the 1.7- and 3.7-kb mRNAs are the major tran- 
scripts (Zheng et al.,  1994). We determined 1.7- and 3.7-kb 
mRNA levels after KGF treatment using Northern blot anal- 
ysis and densitometric scanning. Surprisingly, KGF induced 
downregulation ofHPV mRNA levels in HCE16/3 cells (Fig. 
7). A slight reduction (10%) of HPV16 E7 1.7-kb rnRNA ex- 
pression was observed after 8 h (20 ng/ml) and the inhibition 
became  stronger with  longer duration  of KGF treatment 
(Fig. 7, right part),  After 24-48 h the HPV16 early gene ex- 
pression had markedly declined (,v80% inhibition). The 3.7- 
kb mRNA appeared to be reduced more within 8-12 h (inhi- 
bition 40-50%), but the late reduction was similar to that of 
the  1.7-kb species.  These different effects of KGF on the 
HPV16 1.7- and 3.7-kb mRNAs suggested that these RNAs 
are separately regulated. The effect of KGF on HPV16 E7 
mRNA  expression  was  reproducible  in  dose-dependence 
studies. Cultures on HCE16/3 cells were treated with KGF 
(10--100 ng/ml) for 24 h  (Fig. 7, left part).  In the presence 
of 10 ng/ml of KGF, the E7 1.7-kb mRNA expression was in- 
hibited by ,~70%, and in the presence of 100 ng/ml of the 
growth factor it was inhibited by '~80%. Rehybridization of 
the filter to eDNA of  GAPDH, a housekeeping gene, demon- 
strated that similar amounts of RNA were present in each 
slot. Higher concentrations of  KGF were not used, since they 
were considered unphysiologieal. 
To exclude the possibility that the transcripts are initiated 
at a second promoter which is located in the E70RF (Bthm 
et al., 1993), the Northern blotting was repeated by hybrid- 
ization with a HPV16 E6 probe, spanning the 5' part of the 
E60RF (B6hm et al.,  1993). The results demonstrated that 
HPV16 E6 mRNA was also inhibited by KGF treatment (Fig. 
8), suggesting the inhibited transcripts are indeed initiated 
at the promoter p97 which is responsible for transcription of 
both early genes E6 and E7.  Fig.  8 shows that E6 and E7 
were cotranscribed in both HPV16-positive carcinoma ceils 
(SiHa) and in the HPV16 DNA- immortalized human uterine 
exocervical epithelial cells,  suggesting that continuous ex- 
Figure 7. Northern blot analysis of the effect of KGF on HPVI6 E7 
mRNA expression in HCE16/3 cells. Proliferating HCE16/3 cells 
were exposed to KGF and cells were harvested at different times. 
Total RNA was isolated by lysis of cells in guanidine thiocyanate 
and centrifugation through a CsCI cushion. 25 #g of RNA were 
fractionated on a 1.2% agarose gel containing 6.6% formaldehyde, 
transferred to membranes and the hybridization was performed as 
previously  described.  After  hybridization with  the  HPV16 E7 
probe, the membrane was rehybridized with GAPDH probe used 
as a control for RNA loading. Inhibition of the 3.7- and  1.7-kb 
mRNA species is shown after different times and doses of KGF 
treatment. 
Figure 8. Northern blot analysis of the effect of KGF on HPV16 E7 
and E6 mRNA expression in SiHa and HCE16/3 cells. Proliferating 
SiHa cells and HCE16/3 cells were exposed to 25-50 ng/ml of KGF 
for 24--48 h. Northern blot was carried out as described. HPV16 
E7 expression in SiHa ceils was not affected by KGF treatment; 
HCEI6/3  cells were used as a control.  After hybridization with 
HPV16 E7 and GAPDH, the filter was washed with solution con- 
taining 50% formamide and Ix  SSC (Ix  SSC  =  0.15 M NaCI, 
0.015 M sodium citrate) at 70°C for 30 min, then Ix SSC and 0.1x 
SDS for 15 min at room temperature. The filter was rehybridized 
with HPV16 E6 probe. 
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tivity  of  HPV  genes  in 
HCE16/13 cells treated with 
KGF determined by  nuclear 
run-on assay.  Nuclei were iso- 
lated from proliferating  cells 
treated with 20 ng/ml of KGF 
for  24  h.  1 /~g  of purified 
insert DNA from plasmids containing HPVI6 and fl-actin was 
immobilized  on a membrane and hybridized to an equal amount of 
radioactivity (6.0 ×  l0  ~ cpm) for 48 h at 42°C. The HPV16 hy- 
bridization signals from KGF-treated  cells were clearly weaker  than 
those from untreated cells whereas/3-actin  gene expression  was not 
influenced. 
pression  of  the viral  early  genes is  required  for  the main- 
tenance  of  the  transformed  phenotype. SiHa  cells,  which  did 
not respond to KGF  in their  [3H]thymidine incorporation, 
did not respond to KGF  in their  HPV16 gene expression 
(Fig.  8). 
To  discriminate  whether  down-regulation  of  HPV16 
mRNA is due to a transcriptional repression or a posttran- 
scriptional process,  nuclear run-on experiments were car- 
ried out to quantitate the elongation rate of initiated tran- 
scripts. Proliferating HCE16/3 cells were incubated for 24 h 
in the presence or absence of 20 ng/ml of KGF, and nuclei 
were  extracted  for  an  in vitro transcription  study in the 
presence of 32p-labeled UTP.  Transcription of the HPVI6 
mRNA was compared to that of/~-actin. The HPV16 hybrid- 
ization signals produced by the labeled run-on transcripts 
from KGF-treated cells were clearly weaker (30% suppres- 
sion according to scanning values) than those from untreated 
cells, whereas/~-actin gene transcripts were not influenced 
(Fig. 9). These data indicate that the KGF-mediated down- 
regulation of HPV16 mRNA, as observed by Northern blot 
analysis, is due to repression of transcription. 
Discussion 
KGF  has  been  demonstrated to  function as  a  paracrine 
growth regulator of epithelial structures both in vitro and in 
vivo (Aaronson et al., 1991; Werner et al., 1992; Guo et al., 
1993; Yan et al., 1993),  whereas its role in malignant trans- 
formation is less well studied. Here we show that KGF has 
profound effects on immortalized epithelial cells in vitro. 
The HPV16  DNA-transfected cervical epithelial cell line 
(HCE16/3)  used in our studies was sensitive to stimulation 
by KGF.  Since more mzSI-KGF  bound to HCE16/3 than to 
HCE cells, we assume that the receptor for KGF (KGFR) is 
upregulated in the immortalized cell line. Upregulation of 
other growth factors and/or their receptors has been found 
in certain human carcinomas (King et al., 1985; Kraus et al., 
1989; McLeskey et al.,  1994) and in HPV16-immortalized 
human keratinocytes (Sizemore and Rorke,  1993).  On the 
other band, the cervical cancer cell line, SiHa, exhibited a 
marked loss of responsiveness of KGF suggesting that it may 
lack KGF receptors or that all the receptors are occupied. 
The lack of complex formation even when a high concentra- 
tion of labeled KGF was used,  speaks for the absence of 
KGFR. This is consistent with the findings by Yah et al. 
(1993) using the prostate cancer model. In their model the 
transformation of epithelial cells lead to alternated splicing 
of the FGFR-2 (bek)  gene and to a  complete shift in the 
receptor specificity from the FGF-R2(HIb) isoform display- 
ing high affinity for KGF to the FGF-R2(IHc) isoform not 
recognizing KGF but having high affinity for the FGF-2 
member of the FGF ligand family. This shift  resulted in an 
autocrine mode of growth stimulation. Thus, epithelial cells 
are able to alter their response to the mitogenic signal by 
KGF when they are in the process of malignant transfor- 
marion. 
The different  responses to KGF suggest that HCE16/3 cells 
have retained a more normal epithelial phenotype than SiHa 
cells.  The existence of wide differences in the biological 
characteristics between immortalized nontumorigenic and 
tumorigenic cells has also been observed in our previous 
work, where HCE16/3 cells failed to grow in soft agarose 
and were not tumorigenic in nude mice (Zheng et al., 1994). 
According to clinical observations there is  a  long course 
from prernalignant cervical epithelial lesions to fully malig- 
nant invasive cells. The behavior of HCE16/3 cells in three- 
dimensional cell cultures bears a close resemblance to the 
early  stages  of  cervical  intraepithelial  neoplasia  (CIN) 
(Zheng et al.,  1994),  and the differences in regulation by 
KGF may indicate that at these CIN stages the cells are still 
controlled by their immediate environment. Carcinoma cells 
have largely escaped from growth control in vivo, they are 
more autonomous and no longer dependent on the availabil- 
ity of external growth factors. 
The  finding that  KGF  induced  anchorage-independent 
growth of HCE16/3  cells  is  not  surprising  since  human 
embryonic skin (HES)  fibroblasts can induce it in HES- 
HCE16/3 cocultures (J.  Zheng and A. Vaheri, manuscript 
submitted for publication), and KGF is an epithelial cell- 
specific  growth  factor produced by  fibroblasts  (Rubin  et 
al.,  1989).  However,  induction of anchorage-independent 
growth by KGF is not as efficient as that induced by HES 
fibroblasts,  indicating that  the  effect may only partly be 
replaced by KGF and that also other factors produced by 
fibroblasts may be involved in our coculture system. Mono- 
clonal neutralizing anti-KGF antibodies (10 ~g/ml; kindly 
provided by Dr. L S. Rubin, Laboratory of Cellular and Mo- 
lecular Biology, National Cancer Institute, Bethesda, MD) 
did not fully block the biological effect of cocultured fibro- 
blasts (data not shown), which is consistent with the above 
observations. 
The mechanism of KGF-stimulated anchorage-indepen- 
dent growth of HCE16/3 cells is unclear. TGFs were the first 
recognized factors able to induce nontransformed cells to 
behave as tumor cells in vitro. Based on our results, we con- 
clude that KGF shares certain functions with TGFs in confer- 
ring a transformed phenotype to nontransformed immortal- 
ized cells. However, it remains to be determined whether the 
soft agarose growth of immortalized cells induced by KGF 
is a typical anchorage-independent growth closely associ- 
ated  with  the  cell's  tumorigenic  capacity.  Based  on  the 
knowledge of the involvement of a number of growth factor 
receptors in malignant progression, it will be important to 
further investigate the role of KGF and KGFR in human epi- 
thelial tumors. 
R is not clear whether the down-regulation of HPV16 E7 
gene expression by KGF was a direct effect or was mediated 
by modulating the levels of trans-acring factors that control 
the activity of e.g., the p97 promoter via complex host intra- 
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lomavirus transcription is regulated by several  distinct en- 
hancers located within a 5' long control region (LCR), which 
responds  to  glucocorticoids,  keratinocyte-specifie factors 
and autoregulation by products of the HPV E2 gene (Sousa 
et al., 1990).  The keratinocyte-dependent enhancer (KDE) 
is likely to contribute to the epithelial cell tropism of HPV, 
and mutational studies have shown that this site is required 
for full enhancement of virus gene expression (Chong et al., 
1990).  Because the target cells of KGF are epithelial, it is 
reasonable to propose that HPV mRNA inhibition may be 
associated  with  KDE.  We  speculate  that  KGF  inhibits 
HPV16  early  gene  expression  through  interference  with 
functions of KDE. KGF could directly interfere with KDE 
or indirectly through interference with cellular factors in the 
immortalized keratinocytes. The enhancer domains of LCR 
also contain binding sites for various cellular factors and al- 
.though their role is not yet defined, it seems likely that they 
influence the transcription of viruses. The previous reports 
have shown that the expression of HPV16 genes is differen- 
tially controlled by cellular factors (Yasumoto et al., 1991). 
The relationship between KGF and these cellular factors re- 
mains to be clarified. 
Another possible mechanism of inhibition of HPV16 early 
gene expression is similar to that by TGF-~I which has been 
shown to down-regulate HPV16  early gene expression in 
HPV16-immortalized human genital epithelial cells by inter- 
ference with a transcription factor (Woodworth et al., 1990). 
Although TGF-B  inhibits  proliferation of epithelial  cells 
through the G1 phase of the cell cycle but not during the S 
phase (Pietenpol et al.,  1990),  the TGF-~/effect on trans- 
formed cells varies significantly, depending on the cell line 
(Fynan and Reiss, 1993). Generally, transformed cells have 
a decreased sensitivity to the antiproliferative effect of TGF-~/ 
and become more resistant to TGF-B in malignant progres- 
sion. One possibility is that TGF-/3 is an autocrine factor in 
HCE16/3 cells and is stimulated by KGF treatment and that 
TGF-B is responsible for the down-regulation of HPV early 
gene  expression  (and  perhaps  also  for  the  anchorage- 
independent growth of these cells). 
The observed reduction of HPV16 mRNA levels prompted 
us to more closely define the KGF effect on HPV16  DNA 
transcription.  From nuclear run-on experiments  we  con- 
elude that the suppression  of HPV16  gene expression by 
KGF is regulated at the levels of initiation of transcription 
rather than posttranscriptionally. The finding that HCE16/3 
cells show selective down-regulation of viral RNA provides 
a useful experimental system to study viral gene expression. 
It remains to be determined whether the inhibition of HPV 
mRNA expression by KGF is reversible or irreversible or 
whether  the  effect  of  KGF  on  HPV  expression  varies 
significantly in different  cell lines like that of TGF-B (Fynan 
and Reiss,  1993). 
The biological significance of KGF to down-regulate HPV 
early gene expression is not clear.  Although it has been es- 
tablished that HPV  DNA  expression  is required  for cell 
transformation and for the maintenance of the transformed 
state, these requirements are not absolute. The precise role 
of E6 and E7 in these processes is still a matter of debate, 
and the relationship between cell growth and viral gene ex- 
pression remains controversial. Woodworth et al. (1990) ex- 
amined whether cell growth affected viral gene expression. 
They found that HPV RNA expression was similar in three 
conditions, in rapidly proliferating cells, when cultures were 
maintained in growth factor-deficient medium, and at con- 
fluent density. This meant that HPV gene expression was 
not necessarily inhibited by growth arrest. Agarwal et al. 
(1994)  found that retinoid-dependent changes in  HPV16- 
immortalized cervical cell proliferation do not always corre- 
late with changes in E6/E7 transcript levels. In contrast, in- 
hibition of the growth rate was found to down-regulate HPV 
E6  and E7  genes in  C4-1 cervical  carcinoma ceils  (von 
Knebel-Doeberitz, 1988) and the downregulation of HPV18 
mRNA correlated directly with cessation of cellular growth 
(Rtsl et al., 1988).  Our results are consistent with those of 
Woodworth and Agarwal, showing the viral mRNA and cel- 
lular growth of HCE16/3 cells are probably controlled by 
different genes; thus viral mRNA does not directly modulate 
cell growth in our model. 
Although it is clear the some members of the FGF family 
are oncogenic (Basilico and Moscatelli, 1992), so far noth- 
ing is known about the oncogenic potential of KGF. Guo et 
al. (1993) found that certain regions of the hyperthickened 
skin in old KGF-expressing transgenic animals showed fea- 
tures which were similar to the histopathological findings 
observed during the early stages of papilloma formation. 
Since KGF is a more potent mitogen for epithelial cells than 
EGF or TGF-c~, it is reasonable to hypothesize that KGF may 
play a role in epithelial carcinogenesis. 
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